Cargando…

Adoptive NK Cell Therapy: A Promising Treatment Prospect for Metastatic Melanoma

SIMPLE SUMMARY: The incidence of metastatic melanoma has been increasing over the past years with current therapies showing limited efficacy to cure the disease. Therefore, other options are being investigated, such as adoptive cell therapy (ACT) where activated immune cells are infused into a patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Vliet, Amanda A., Georgoudaki, Anna-Maria, Raimo, Monica, de Gruijl, Tanja D., Spanholtz, Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471577/ https://www.ncbi.nlm.nih.gov/pubmed/34572949 http://dx.doi.org/10.3390/cancers13184722

Ejemplares similares

Early TRAIL-engagement elicits potent multimodal targeting of melanoma by CD34(+) progenitor cell-derived NK cells
por: van Vliet, Amanda A., et al.
Publicado: (2023)

Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer
por: Veluchamy, John Pradeep, et al.
Publicado: (2016)

In Vivo Efficacy of Umbilical Cord Blood Stem Cell-Derived NK Cells in the Treatment of Metastatic Colorectal Cancer
por: Veluchamy, John P., et al.
Publicado: (2017)

Natural killer cells in clinical development as non-engineered, engineered, and combination therapies
por: Lamers-Kok, Nina, et al.
Publicado: (2022)

Enhancement of NK Cell Antitumor Effector Functions Using a Bispecific Single Domain Antibody Targeting CD16 and the Epidermal Growth Factor Receptor
por: Toffoli, Elisa C., et al.
Publicado: (2021)

Standardized and flexible eight colour flow cytometry panels harmonized between different laboratories to study human NK cell phenotype and function
por: Veluchamy, John P., et al.
Publicado: (2017)

Boosting Natural Killer Cell Therapies in Glioblastoma Multiforme Using Supramolecular Cationic Inhibitors of Heat Shock Protein 90
por: Saha, Tanmoy, et al.
Publicado: (2021)

Development of Allogeneic NK Cell Adoptive Transfer Therapy in Metastatic Melanoma Patients: In Vitro Preclinical Optimization Studies
por: Besser, Michal J., et al.
Publicado: (2013)

High-efficiency lysis of cervical cancer by allogeneic NK cells derived from umbilical cord progenitors is independent of HLA status
por: Veluchamy, John P., et al.
Publicado: (2016)

The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments
por: Veluchamy, John P., et al.
Publicado: (2017)

Natural Killer Cells and Anti-Cancer Therapies: Reciprocal Effects on Immune Function and Therapeutic Response
por: Toffoli, Elisa C., et al.
Publicado: (2021)

Future role for adoptive T-cell therapy in checkpoint inhibitor-resistant metastatic melanoma
por: Borch, Troels Holz, et al.
Publicado: (2020)

Adoption of immunotherapy in the community for patients diagnosed with metastatic melanoma
por: Krimphove, Marieke J., et al.
Publicado: (2019)

Combination of Ipilimumab and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma
por: Mullinax, John E., et al.
Publicado: (2018)

Adoptive Cell Therapy for Patients with Melanoma
por: Dudley, Mark E.
Publicado: (2011)

Promises and challenges of adoptive T-cell therapies for solid tumours
por: Morotti, Matteo, et al.
Publicado: (2021)

Elimination of Metastatic Melanoma Using Gold Nanoshell-Enabled Photothermal Therapy and Adoptive T Cell Transfer
por: Bear, Adham S., et al.
Publicado: (2013)

Adoptive cell therapy with tumor infiltrating lymphocytes and intermediate dose IL-2 for metastatic melanoma
por: Andersen, Rikke, et al.
Publicado: (2014)

Immunological effects of everolimus in patients with metastatic renal cell cancer
por: Huijts, Charlotte M, et al.
Publicado: (2017)

CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2
por: Bedognetti, D, et al.
Publicado: (2013)

IL-12 Directs Further Maturation of Ex Vivo Differentiated NK Cells with Improved Therapeutic Potential
por: Lehmann, Dorit, et al.
Publicado: (2014)

Adoptive NK Cell Therapy - a Beacon of Hope in Multiple Myeloma Treatment
por: Vu, Son Hai, et al.
Publicado: (2023)

From simplicity to complexity in current melanoma models
por: Michielon, Elisabetta, et al.
Publicado: (2022)

The Promise of Liquid Biopsy to Predict Response to Immunotherapy in Metastatic Melanoma
por: Fattore, Luigi, et al.
Publicado: (2021)

Expanded NK cells used for adoptive cell therapy maintain diverse clonality and contain long-lived memory-like NK cell populations
por: Allan, David S.J., et al.
Publicado: (2022)

Defining Early Human NK Cell Developmental Stages in Primary and Secondary Lymphoid Tissues
por: Eissens, Diana N., et al.
Publicado: (2012)

Extensive natural killer cell receptor phenotyping on NK and T cells discloses differences in RA and PsA, potentially mirroring diverse immunoregulatory functions
por: van Bijnen, Sandra TA, et al.
Publicado: (2011)

Low-dose interferon-alpha preconditioning and adoptive cell therapy in patients with metastatic melanoma refractory to standard (immune) therapies: a phase I/II study
por: Verdegaal, Els, et al.
Publicado: (2020)

CAR-NK Cells: A Chimeric Hope or a Promising Therapy?
por: Sabbah, Mohamad, et al.
Publicado: (2022)

Emerging NK cell therapies for cancer and the promise of next generation engineering of iPSC-derived NK cells
por: Maddineni, Sainiteesh, et al.
Publicado: (2022)

Minimally invasive liver resection to obtain tumor-infiltrating lymphocytes for adoptive cell therapy in patients with metastatic melanoma
por: Alvarez-Downing, Melissa M, et al.
Publicado: (2012)

Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients
por: Ellebaek, Eva, et al.
Publicado: (2012)

Prospects for NK Cell Therapy of Sarcoma
por: Lachota, Mieszko, et al.
Publicado: (2020)

Melanoma immunoediting by NK cells
por: Balsamo, Mirna, et al.
Publicado: (2012)

Immune correlates of melanoma survival in adoptive cell therapy
por: Lee, Agnes Fermin, et al.
Publicado: (2013)

Ipilimumab, a Promising Immunotherapy with Increased Overall Survival in Metastatic Melanoma?
por: Piérard, Gérald E., et al.
Publicado: (2012)

Correction: Emerging NK cell therapies for cancer and the promise of next generation engineering of iPSC-derived NK cells
Publicado: (2022)

NK Cells in the Tumor Microenvironment as New Potential Players Mediating Chemotherapy Effects in Metastatic Melanoma
por: Garofalo, Cinzia, et al.
Publicado: (2021)

IDO and galectin-3 hamper the ex vivo generation of clinical grade tumor-specific T cells for adoptive cell therapy in metastatic melanoma
por: Melief, Sara M., et al.
Publicado: (2017)

Intralesional therapy for advanced melanoma: promise and limitation
por: Agarwala, Sanjiv S.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_og7o4cgcn9nmtvlhlgoab4d55h